Orchid is an India-based pharmaceutical company involved in manufacturing, development and marketing of diverse bulk actives, formulation and nutraceuticals. Through this acquisition, Orchid has created its presence in
The QN Diagnostics (QND) Q-Reader is a stand-alone instrument with a liquid crystal display (LCD) touch screen located on the top of the unit, and an integrated software
According to Eisai, the arrangement covers the development of a combination antiemetic agent (in both oral and intravenous forms) containing netupitant (generic name), a neurokinin-1 (NK1) receptor antagonist,
Understanding the PI3K pathway is essential in developing new medicines to inhibit or block this pathway, thereby cutting off a metabolic function needed for certain cancers to survive.
The safety warning from Health Canada notes that patients using Champix in an effort to quit smoking should be aware that neuropsychiatric side effects have occurred in people
Prasita is an antiplatelet agent for the prevention of atherothrombotic events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Prasita is solely marketed by Ranbaxy in
Sucampo claimed that the trial met its primary endpoint with statistical significance and demonstrated a safety profile consistent with previously reported clinical lubiprostone data. The primary endpoint of
Protagen and Bayer Schering Pharma aim to evaluate the UNIarray technology for discovery of autoantibody patterns for the predictive diagnosis of endometriosis. Peter Schulz-Knappe, CSO and executive vice
OvaCheck is a multivariate index assay that measures the relative ratios of eight proteins. It employs a bead-based multiplexed immunoassay platform and Correlogic’s proprietary software system to return
GPSG Brazil is expected to use ‘Connects’ to enhance the quality control in its Sao Jose dos Campos pharmaceutical production facility in Sao Paulo Brazil. GPSG Brazil plans
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.